APRIL 1-2, 2025 / Basel, Switzerland
Pharma Partnering Conference
BASEL | 2025
Driving Innovation Through Strategic Collaborations
What to expect
At the Pharma Partnering Conference, we’re addressing the most pressing challenges in the pharmaceutical industry – such as building strategic partnerships, staying ahead of market shifts, and identifying new growth opportunities. This conference brings together industry leaders, biotech innovators, and investors to explore the transformative power of collaborations across the value chain.
Unlike large trade shows, our boutique-style format offers a unique chance to interact with a targeted group of 100+ senior decision-makers and 25+ expert speakers, ensuring effective relationship-building and long-term business growth.
What to Expect:
- Visionary Keynote Presentations
- Matchmaking Sessions
- Engaging Panel Discussions
- Unmatched Networking Opportunities
We focus on long-term cooperation and are ready to offer valuable opportunities to support your goals. Don’t miss your chance to be part of this transformative event – register now and secure your spot!
Main takeaways
- The Power of Partnerships: Learn how collaborations across research, clinical development, and manufacturing are shaping the future of pharma.
- Deal-Making Strategies: Discover best practices in structuring and executing deals that maximize value for all parties.
- Innovative Technologies: Explore the role of AI in drug discovery, clinical trial designs, and diagnostics, moving beyond the hype to real-world applications.
- Investment Insights: Gain an investor’s perspective on what drives confidence in early-stage biotech companies and how to position your venture for success.
- Biotech and Big Pharma Collaborations: Understand the complexities of dealmaking between biotech companies and big pharma, and learn how to navigate these partnerships for mutual benefit.
Everything you need to know about this event in one spot.
Check out our event overview and agenda and discover Pharma Partnering Conference Basel 2025.
Event Speakers
Huseyin Ocak
Global Alliance Management Lead, Consumer Healthcare
Opella
Xiaona Jing
SVP Global Product Development & Partnering at Multitude Therapeutics
Multitude Therapeutics
Isabella Visconti
Founder
Visconti Alliance Management
Gabriela M. Visser
Founder & CEO
Q-Pro Laboratories B.V.
Luis Correia
Founder & CEO
Basel Biotech Consulting
Kurt Herpel
CEO
Delta4
Hiro Usuda
Scouting & Transaction Lead, Business Development
Astellas Pharma
Charlie Bailey
BD&L Transactions Head, Global Health, Corporate & Business Development
Novartis AG
Ana Paula Tediosi
Head of Expanded Access Program Strategy
WEP Clinical
Louise Jopling
Chief Scientific & Innovation Officer
Babraham Research Campus
Event Partners
Silver Sponsor
Tillotts Pharma AG is a Swiss-based, well-established and fast-growing pharmaceutical specialty company with global reach and M&A expertise. It has sales of around a third a billion USD and a sustainable double-digit average annual sales growth. Tillotts with its around 400 employees is part of the Japanese Zeria Group.
Tillotts is successfully marketing own, acquired and/or in-licensed specialty products in two core disciplines of gastrointestinal and infectious diseases.
This continued success and strong track record in partnering is based on coverage of 24 key European markets with own affiliates, a proven network of dedicated commercial partners in 40+ markets, lean processes and strong teams for the integration of new products, combined with extensive expertise in market access and regulatory matters in- and outside Europe.
Tillotts is particularly interested in acquiring and/or in-licensing late-stage pharmaceutical products treating gastrointestinal and infectious diseases and additionally specialty hospital products.
Silver Sponsor
At WEP Clinical, we are With Every Patient, as we believe every patient has the right to treatment! With this as our guiding principle, we have created a market leading, solutions driven, healthcare services company that partners with drug developers (Sponsors) to create broader treatment access solutions for patients worldwide. We take pride in the high-quality output and positive customer experience we create while delivering our services.
Elevate partner
Delta4 is a digital drug discovery TechBio company founded in 2019 in Vienna, Austria. Specializing in AI-driven drug repurposing and indication expansion, Delta4 utilizes its proprietary Hyper-C platform to accelerate the identification of new therapeutic applications for existing compounds. Focused on tackling complex and rare diseases, Delta4 collaborates with pharmaceutical companies, universities, and clinics to bring innovative treatments to market efficiently.
Industry Pioneers Attending From
Testimonials
REGISTRATION
2-DAY CONFERENCE PARTNERING
Ticket | April 1-2, 2025-
Access to All Conference Sessions
-
Access to Post Conference Networking
-
Conference Materials
-
Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch
2-DAY CONFERENCE PPM
Ticket | April 3-4, 2025-
Access to All Conference Sessions
-
Access to Post Conference Networking
-
Conference Materials
-
Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch
ELEVATE PACKAGE
Ticket | April 1-2, 2025-
15-min speaking slot to present your company and partnering opportunities.
-
1 delegate pass for the presenter.
-
Social media shoutout to highlight your session.
ENGAGE PACKAGE
Ticket | April 1-2, 2025-
Access to our networking app to organize one-on-one meetings with attendees.
-
Exhibition space (includes table setup). 2 delegate passes.
-
Social media shoutout to amplify your presence.
BECOME A PARTNER
OF this EVENT-
Present on the Main Stage
-
Hold an exhibit at this event
-
Showcase your Brand in Marketing Material
-
Gain exposure through alternative partnership benefits
